Magle Chemoswed congratulates everyone at Oncopeptides for receiving FDA approval of PEPAXTO®. We are proud to have been chosen by Oncopeptides as a development and manufacturing partner for the active pharmaceutical substance. It has been a great pleasure to support Oncopeptides and supply development and manufacturing services around the active pharmaceutical substance through all phases of the...

Magle Chemoswed joins collaboration with Malmö University on exciting new project. The project will focus on the use of the Company technology platform as a novel delivery system in conjunction with proteins. Protein-based therapeutics are becoming increasingly popular in medicine. Compared to low molecular drugs, they are more specific, cause fewer side effects and are environmentally friendly. ...